论文部分内容阅读
用血脂康(ｘｕｚｈｉｋａｎｇ,Ｘｕｅ)治疗原发性高脂血症患者33例,与烟酸肌醇酯(ｉｎｏｓｉｔｏｌｎｉｃｏｔｉｎａｔｅ,ＩＮ)相比较,以观察血脂康治疗高脂血症的疗效。1 资料与方法1.1 病例选择 根据1993年7月卫生部药政司制定的《新药(西药)临床研究指导原则》的高血脂诊
Thirty-three patients with primary hyperlipidemia were treated with xuzhikang (Xue) and compared with inositolnicotinate (IN) to observe the therapeutic effect of Xuezhikang on hyperlipidemia. 1 Materials and Methods 1.1 Case Selection According to July 1993 Department of Pharmacology, the Ministry of Health to develop “new drug (Western medicine) clinical research guidelines” of hyperlipidemia